pharmaceutical industry

Meeting the global health challenge: the role of the pharmaceutical industry

By Making It on 31 October, 2012

Professor Klaus M. Leisinger, chair of the Novartis Foundation for Sustainable Development, explores some of the issues at the intersection between industry and health.

Posted in All Posts, Features | Tagged access to medicines, Africa, Arogya Parivar, basic health rights, counterfeit medicines, CSR, generics, Global Alliance for Vaccines and Immunization, global health, intellectual property, Klaus M. Leisinger, LDCs, Making It, malaria, MDGs, Medicines for Malaria Venture, Millennium Development Goals, non-governmental organizations, Novartis, Novartis Foundation for Sustainable Development, pharmaceutical industry, public health resources, research-based pharmaceutical corporations, sanitation, UN Global Compact, Working Group on Access to Essential Medicines, World Health Organization Essential Medicines List, World Health Report

Quality medicines for all

By Making It on 3 October, 2012

Jürgen Reinhardt on the latest developments regarding the local production of pharmaceuticals in Africa.

Posted in All Posts, Features | Tagged Africa, African pharmaceutical manufacturers, AU Pharmaceutical Manufacturing Plan for Africa, drug regulatory authorities, Global Fund to Fight Aids, Good Manufacturing Practices, Investment and Technology Services Branch, Jürgen Reinhardt, LPP, Making It magazine, medicines, pandemics, patients, pharmaceutical industry, public health systems, Sub-Saharan Africa, Tuberculosis and Malaria, UNIDO Business

pharmaceutical industry

Meeting the global health challenge: the role of the pharmaceutical industry

Quality medicines for all

Feeds

Print editions

Archives

Login